AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17612657
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of adenosine (12 microg/bolus) and sodium nitroprusside (50 microg/bolus)
Trial: 7890239
Drug: 30 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/kg ALA
Trial: 7890239
Drug: 60 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg/kg ALA
Trial: 7890239
Drug: Red laser
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red laser light (628 nm) treatment after ALA administration
Trial: 1835398
Drug: Clodronate (1.6g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clodronate (1.6g orally daily for 18 months)
Trial: 6119766
Drug: Pirenzepine 50
RxNorm normalized name: pirenzepine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine 50 mg twice a day
Trial: 6119766
Drug: L-hyoscyamine 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-hyoscyamine 0.6 mg twice a day
Trial: 27600941
Drug: Social Recovery
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social Recovery Cognitive Behavioural Therapy (SRCBT)
Trial: 27600941
Drug: Both SRCBT
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both SRCBT and Treatment as usual
Trial: 24359938
Drug: Oral ibuprofen
RxNorm normalized name: ibuprofen Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ibuprofen (initial dose of 10 mg/kg, followed by 5 mg/kg at 24 and 48 hours)
Trial: 24359938
Drug: Oral paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral paracetamol (15 mg/kg every 6 hours for 3 days)
Trial: 21292439
Drug: Voice therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voice therapy after BTX‐A injection
Trial: 21292439
Drug: Sham voice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham voice therapy after BTX‐A injection
Trial: 16382596
Drug: Adper Prompt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adper Prompt L-Pop (3M ESPE)
Trial: 2215986
Drug: Halothane (0.8%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Halothane (0.8% end-tidal) with atracurium (0.35 mg/kg)
Trial: 2215986
Drug: Isoflurane (1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflurane (1% end-tidal) with atracurium (0.35 mg/kg)
Trial: 626731
Drug: Pulsed oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pulsed oxytocin infusion (infused for one minute every ten minutes using a modified Cardiff Infusion System Mark III)
Trial: 28973362
Drug: Chemotherapy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy followed by allo‐HSCT (HSCT group)
Trial: 28973362
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (chemotherapy group)
Trial: 28973362
Drug: Conventional chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional chemotherapy (adult regimen)
Trial: 23106093
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy (2 hours of structured exercise weekly for 6 months)
Trial: 23106093
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy (2 hours weekly for 6 months)
Trial: 18844760
Drug: Antihypertensive drug
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive drug treatment (perindopril, amlodipine, or labetalol)
Trial: 16140433
Drug: M01ZH09 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M01ZH09 vaccine at 5 x 10(9) CFU
Trial: 16140433
Drug: M01ZH09 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M01ZH09 vaccine at 5 x 10(8) CFU
Trial: 16140433
Drug: M01ZH09 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M01ZH09 vaccine at 5 x 10(7) CFU
Trial: 13680163
Drug: Megestrol (total
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Megestrol (total dose 320 mg)
Trial: 13680163
Drug: Hydrocortisone (total
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (total dose 30 mg)
Trial: 8775253
Drug: Depot goserelin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depot goserelin acetate, 3.6 mg, subcutaneously at 4-weekly intervals
Trial: 8775253
Drug: Danazol, 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol, 600 mg/day
Trial: 1486391
Drug: Intravenous epirubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous epirubicin 90 mg/m2 every 28 days
Trial: 29893144
Drug: Glucose-dependent therapies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-dependent therapies (Strategy A)
Trial: 29893144
Drug: Glucose-independent therapies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-independent therapies (Strategy B)
Trial: 25956287
Drug: Coumarin anticoagulants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coumarin anticoagulants
Trial: 21266513
Drug: Accelerated vaccination
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated vaccination schedule (10 μg HBvaxPRO, 0-1-3 week schedule)
Trial: 21266513
Drug: Standard vaccination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard vaccination schedule (10 μg HBvaxPRO, 0-4-24 week schedule)
Trial: 16825691
Drug: Drink B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drink B (CPP-enriched preparation, 1.7 g CPP, 400 mg Ca as calcium lactate)
Trial: 16825691
Drug: Drink C
RxNorm normalized name: Boost Energy Drink Chocolate Raspberry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drink C (CPP-enriched preparation, 1.7 g CPP, 400 mg Ca as calcium lactate)
Trial: 16825691
Drug: Drink A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drink A (calcium lactate drink, 400 mg Ca as lactate)
Trial: 7845645
Drug: Indomethacin suspension
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin suspension
Trial: 29304325
Drug: L-PRF-plus-HA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-PRF-plus-HA
Trial: 28070894
Drug: TAS-102 tablets
RxNorm normalized name: Ta
DrugBank: TAS-102 (DB08937)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAS-102 tablets (60 mg; 3 × 20-mg tablets)
Trial: 28070894
Drug: TAS-102 oral
RxNorm normalized name: Ta
DrugBank: Tantalum (DB12859)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAS-102 oral solution (60 mg)
Trial: 25824212
Drug: Benznidazole (BNZ)
RxNorm normalized name: benznidazole
DrugBank: Benznidazole (DB11989)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benznidazole (BNZ) at 2.5 mg/kg of body weight/12 h for 60 days
Trial: 20981000
Drug: MK-0249 50
RxNorm normalized name: vitamin MK 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-0249 50 mg
Trial: 20981000
Drug: MK-0249 10
RxNorm normalized name: vitamin MK 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-0249 10 mg
Trial: 15845499
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of tetravalent polysaccharide vaccine for children >/=24 months old
Trial: 15845499
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of tetravalent polysaccharide vaccine for children </=18 months old
Trial: 11918735
Drug: 35 mmol/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 mmol/L lactate dialysate
Trial: 10342622
Drug: Intra-articular Sm-153
RxNorm normalized name: SM-153
DrugBank: Samarium Sm-153 (DB12905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular Sm-153 PHYP combined with 40 mg triamcinolone hexacetonide
Trial: 10342622
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg intra-articular triamcinolone hexacetonide alone
Trial: 9196767
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral dose of 500 mg artemisinin with a single 500 mg oral dose of mefloquine (AM)
Trial: 9196767
Drug: Mefloquine therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefloquine therapy alone (M)
Trial: 24206527
Drug: Laropiprant 40mg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laropiprant 40mg, clopidogrel 75mg, and aspirin 80mg (Study 1) or 81mg (Study 2) once daily for 7 days
Trial: 24206527
Drug: Placebo, clopidogrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, clopidogrel 75mg, and aspirin 80mg (Study 1) or 81mg (Study 2) once daily for 7 days
Trial: 20889603
Drug: Symptom diary
RxNorm normalized name: Pamprin Multi-Symptom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptom diary group (daily use for 14 days)
Trial: 18552684
Drug: Aerosol antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosol antibiotic (AA)
Trial: 15876307
Drug: Prednisolone (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (oral glucocorticoid), 1 dose per day for 2 weeks
Trial: 10087548
Drug: CapSure Z
RxNorm normalized name: Z-160
DrugBank: Z-160 (DB12743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CapSure Z leads (1.2 mm2 surface area; steroid-eluting)
Trial: 10087548
Drug: CapSure SP
RxNorm normalized name: SPS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CapSure SP leads (5.8 mm2 surface area; steroid-eluting)
Trial: 10087548
Drug: CapSure leads
RxNorm normalized name: lead
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CapSure leads (8 mm2 surface area; steroid-eluting)
Trial: 10087548
Drug: Target Tip
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Target Tip leads (8 mm2 surface area; no steroid elution)
Trial: 7723402
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of recombinant human granulocyte‐macrophage colony‐stimulating factor (rhGM‐CSF) 5 micrograms/kg/day
Trial: 7723402
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of rhGM‐CSF administered subcutaneously every 24 h
Trial: 8225680
Drug: Phentermine HCl
RxNorm normalized name: phentermine HCl
DrugBank: Phentermine (DB00191)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phentermine HCl capsules (Minobese Forte)
Trial: 8225680
Drug: Phentermine base
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phentermine base capsules (Duromine)
Trial: 31951263
Drug: Early intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early intervention group (n = 80) receiving one-on-one physical therapy 8 times over 6 weeks and daily home exercises with wearable sensors
Trial: 18622294
Drug: Prophylaxis followed
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylaxis followed by preemptive therapy (ganciclovir for 30 days, then preemptive therapy with virologic monitoring)
Trial: 18622294
Drug: Preemptive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preemptive therapy alone (initiated at 100,000 DNA copies/mL whole blood)
Trial: 18622294
Drug: Both arms
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both arms (prophylaxis and preemptive therapy)
Trial: 16001108
Drug: Alprazolam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (0.5 mg b.i.d.)
Trial: 12450909
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (5 mg elemental Zn/d)
Trial: 10614677
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens 0.625 mg/day continuously
Trial: 10614677
Drug: Transdermal 17beta‐estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17beta‐estradiol 50 mg/day continuously
Trial: 7864416
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl infusion (2 micrograms/mL at 4‐10 mL/h)
Trial: 7864416
Drug: IV morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV morphine via patient-controlled analgesia (IV‐PCA)
Trial: 7864416
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl infusion and IV morphine via PCA
Trial: 7191614
Drug: E2 and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2 and E3 orally in doses of 4-8 mg per day for 3 weeks
Trial: 7191614
Drug: Gestagen (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestagen (1000 mg i.m. injection)
Trial: 24113039
Drug: Argatroban (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argatroban (200 µg/kg bolus, followed by 350 µg·kg(‐1)·h(‐1) i.v. infusion)
Trial: 24113039
Drug: Heparin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (100 U/kg via artery sheaths)
Trial: 19906103
Drug: Anti-EGFR monoclonal
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Anti-EGFR monoclonal antibody
Trial: 19906103
Drug: No anti-EGFR
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No anti-EGFR monoclonal antibody (Control)
Trial: 17293063
Drug: 200 microg
RxNorm normalized name: Digoxin 200 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 microg L-selenomethionine daily for 6 months
Trial: 15510787
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment in addition to routine diabetes treatment
Trial: 15510787
Drug: Domperidone treatment
RxNorm normalized name: Domperidone
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone treatment in addition to routine diabetes treatment
Trial: 15510787
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment in addition to routine diabetes treatment
Trial: 2979273
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg taken at 18.15 hours after a standard meal at 18.00 hours
Trial: 2979273
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg taken at 18.15 hours after a late meal at 22.00 hours
Trial: 12719279
Drug: Ezetimibe (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe (10 mg) plus atorvastatin (10, 20, 40, or 80 mg)
Trial: 17560879
Drug: Atorvastatin (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (10, 20, 40, or 80 mg)
Trial: 8994512
Drug: LY293111 (112
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY293111 (112 mg three times daily for seven days)
Trial: 1453314
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy of chlorpheniramine and cimetidine
Trial: 3933202
Drug: Pyoimmunogen vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyoimmunogen vaccine
Trial: 31174360
Drug: 75% basal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75% basal insulin dose
Trial: 31174360
Drug: Both trial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both trial arms (75% and 100% basal insulin)
Trial: 19709787
Drug: 8.8 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8.8 g/d of plant stanols as esters
Trial: 16061711
Drug: Sildenafil 25
RxNorm normalized name: sildenafil 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 25 mg 8 hourly for 12 weeks (n = 9)
Trial: 16061711
Drug: Sildenafil 100
RxNorm normalized name: sildenafil 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 100 mg 8 hourly for 12 weeks (n = 5)
Trial: 1826370
Drug: Diclofenac (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (200 mg/day for 4 days)
Trial: 6123337
Drug: Lorazepam 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam 0.05 mg kg‐1
Trial: 6123337
Drug: Trimeprazine 3
RxNorm normalized name: trimeprazine 30 MG per 5 ML Syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimeprazine 3 mg kg‐1
Trial: 25018142
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy with B blockers
Trial: 22459327
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy plus healthy living skills
Trial: 22459327
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy plus affect regulation training
Trial: 19007927
Drug: Wire-guided cannulation
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wire-guided cannulation (WGC) without contrast injection
Trial: 19007927
Drug: Conventional cannulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional cannulation with contrast injection
Trial: 15364317
Drug: Immune modulation
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immune modulation therapy (IMT)
Trial: 11278160
Drug: 100mcg transdermal
RxNorm normalized name: fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 100mcg transdermal estradiol
Trial: 11278160
Drug: 50mcg transdermal
RxNorm normalized name: fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 50mcg transdermal estradiol
Trial: 9549810
Drug: Control arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control arm (no Tamoxifen treatment)
Trial: 8015795
Drug: Experimental dressing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental dressing (chlortetracycline, aspirin, local anesthetics)
Trial: 1257731
Drug: Long-time treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-time treatment with corticosteroids and azathioprine
Trial: 1257731
Drug: Short-time treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-time treatment (as short as possible)
Trial: 31164148
Drug: 540,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 540,000 IU cholecalciferol followed by monthly supplementation
Trial: 31164148
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D oral supplementation
Trial: 28739541
Drug: Virtual Advisor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virtual Advisor program (computer-based embodied conversational agent named 'Carmen')
Trial: 16827769
Drug: 15 ml
RxNorm normalized name: ethanol 0.15 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 ml of 0.5% bupivacaine
Trial: 16827769
Drug: 15 ml
RxNorm normalized name: ethanol 0.15 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 ml of 0.9% saline (control)
Trial: 15457989
Drug: Timolol-gel alone
RxNorm normalized name: timolol Ophthalmic Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol-gel alone
Trial: 15457989
Drug: Timolol-gel and
RxNorm normalized name: timolol Ophthalmic Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol-gel and latanoprost in combination
Trial: 8282290
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg, increased to 10 mg if diastolic BP > 90 mmHg
Trial: 2941290
Drug: Ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 500 mg b.i.d. for five days
Trial: 18320916
Drug: Albuterol nebulizer
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol nebulizer (2.5 mg)
Trial: 17036557
Drug: 1 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g/d of valacyclovir for 60 days
Trial: 15529837
Drug: Oral antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antibiotics (7-day outpatient course)
Trial: 3526609
Drug: Prostacyclin (PGI2)
RxNorm normalized name: PGI2
DrugBank: Epoprostenol (DB01240)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prostacyclin (PGI2) treatment (6 ng/kg/min, n = 13)
Trial: 20484472
Drug: Testosterone gel
RxNorm normalized name: Androgel 1.62% Metered Dose Pump Testosterone Gel
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone gel 7.5 g daily
Trial: 9759991
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) 20 mg b.i.d. for 8 weeks (could be doubled once)